![Stuart Marcus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Stuart L.
Marcus is the founder of SonALAsense, Inc., founded in 2019, serving as Director & Chief Scientific Officer since 2023.
The current job is Chief Medical Officer & VP-Scientific Affairs at DUSA Pharmaceuticals, Inc., starting in 1993.
Former job includes Director-Hematology & Oncology Department at DaIIchi Pharma Holdings, Inc.
Actieve functies van Stuart Marcus
| Bedrijven | Functie | Begin |
|---|---|---|
DUSA Pharmaceuticals, Inc.
 DUSA Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets photodynamic therapies & dermatological pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | 11-10-1993 |
SonALAsense, Inc.
 SonALAsense, Inc. Medical SpecialtiesHealth Technology Operates as a clinical-stage biotechnology company focused on developing a new cancer treatment | Oprichter | 01-01-2019 |
Eerdere bekende functies van Stuart Marcus
| Bedrijven | Functie | Einde |
|---|---|---|
DaIIchi Pharma Holdings, Inc. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
22
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
DUSA Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets photodynamic therapies & dermatological pharmaceutical products | Health Technology |
DaIIchi Pharma Holdings, Inc. | |
SonALAsense, Inc.
SonALAsense, Inc. Medical SpecialtiesHealth Technology Operates as a clinical-stage biotechnology company focused on developing a new cancer treatment | Health Technology |
